SecBot SecBot
EFFECT ·Filed Sep 15, 2026

BRNS

Barinthus Biotherapeutics plc.
NEUTRAL
Impact 4/10
Horizondays Processed1mo ago SEC9999999995-26-002957
IPO/offering going effective
Actionable Insight • Neutral

Monitor for the company's next pricing announcement or prospectus supplement to determine the offering size and terms. The effectiveness enables share sales, so watch for potential dilution pressure on the stock in the near term.

DirectionNeutral
Confidencemedium
Horizondays
Latest settled — T+5d
BRNS ▲ 0.00% at T+5d
NEUTRAL call 0.00% · α vs SPY -0.82% · entry $0.7400 → $0.7400
Next anchor: T+20d due 15d ago
Entry = T+0 close
Sep 15, 2026
via day close
T+1d
0.00%
call 0.00% · α +0.44%
$0.7400
settled 6w ago
T+5d
0.00%
call 0.00% · α -0.82%
$0.7400
settled 5w ago
T+20d
Pending
due 15d ago
T+60d
Pending
in 6w

Price Chart

Loading chart...

Executive Summary

Barinthus Biotherapeutics plc's registration statement has become effective, allowing the company to proceed with its securities offering. The company can now sell shares, which may create potential dilution overhang for existing shareholders.

Key Facts

  • Form EFFECT filed, indicating the registration statement is now effective.
  • Company: Barinthus Biotherapeutics plc (BRNS), a pharmaceutical company.
  • Market cap: $30M.
  • No specific offering size or terms disclosed in the filing.

Financial Impact

Undisclosed offering size; potential dilution overhang given the company's $30M market cap.

dilutionshare price

Risk Factors

  • Potential dilution from the now-effective offering.
  • Uncertainty regarding the offering's size and pricing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (8 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-002957
Document: 9999999995-26-002957-index.html9999999995-26-002957
Document: 9999999995-26-002957.txt9999999995-26-002957
5 reports for BRNS
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for BRNS — sortable, filterable
TypeNow
Sep 15, 2026
6w ago
EFFECT
NEUTRAL ★ 4/10
$0.7400awaiting T+20——
Aug 25, 2026
9w ago
8-K
MIXED ★ 7/10
$0.6600awaiting T+20——
Jul 2, 2026
16w ago
8-K
BEARISH ★ 6/10
$0.6201 $0.5570▲ +10.18%▲ +9.76%—
May 1, 2026
25w ago
3
NEUTRAL ★ 2/10
$0.6350 $0.6810▲ +7.24%▲ +1.60%—
Mar 13, 2026
32w ago
Press Release
BEARISH ★ 7/10
$0.6290 $0.5500▲ +12.56%▲ +16.15%—
Showing 5 of 5

US Market Status

Market Closed — Opens Thu (12h 57m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 15, 2026